Related references
Note: Only part of the references are listed.An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
Jotam Pasipanodya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antibacterial Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Micafungin in Adult Lung Transplant Patients
Thomas J. Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
Tawanda Gumbo
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients
John E. Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Emerging Bacterial, Fungal, and Viral Respiratory Infections in Transplantation
Shawn P. E. Nishi et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Emerging, Novel, and Known Influenza Virus Infections in Humans
Julian W. Tang et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Tuberculosis in the Global Aging Population
Toru Mori et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
Shahid Husain et al.
TRANSPLANTATION (2010)
Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers
Anthony M. Nicasio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
John E. Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole
Keith A. Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations
Stefan Weiler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
Sylvain Goutelle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis
Olaf Burkhardt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Low-dose inhaled versus standard dose oral form of anti-tubercular drugs: Concentrations in bronchial epithelial lining fluid, alveolar macrophage and serum
S Prakash et al.
Journal of Postgraduate Medicine (2009)
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations
Andreas H. Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen
B Capitano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Detection of HIV protease inhibitors in alveolar epithelial lining fluid: Relevance for modulation of Pneumocystis infection in the course of HAART
Chiara Atzori et al.
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2006)
Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin
JE Conte et al.
CLINICAL PHARMACOKINETICS (2004)
Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient
C Atzori et al.
AIDS (2003)
Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
V Monforte et al.
TRANSPLANTATION (2003)
Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy
HM Ziglam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
